Acute 5-HT reuptake blockade potentiates human amygdala reactivity
- PMID: 18463627
- PMCID: PMC2858321
- DOI: 10.1038/npp.2008.52
Acute 5-HT reuptake blockade potentiates human amygdala reactivity
Abstract
Variability in serotonin (5-HT) function is associated with individual differences in normal mood and temperament, as well as psychiatric illnesses, all of which are influenced by amygdala function. This study evaluated the acute effects of 5-HT reuptake blockade on amygdala function using pharmacological functional MRI. Eight healthy men completed a double-blind balanced crossover study with the selective 5-HT reuptake inhibitor, citalopram (20 mg infused over 30 min), and normal saline. Amygdala reactivity in response to novel facial expressions was assessed on three successive scans, once before drug/placebo infusion, once early in the infusion, and once at the end of infusion. Acute citalopram administration resulted in concentration-dependent increases in human amygdala reactivity to salient stimuli. The current pattern of 5-HT-mediated amygdala reactivity may represent an important pathway through which SSRIs achieve an antidepressant effect. Intriguingly, our data may also reveal a mechanism contributing to clinical observations of extreme agitation, restlessness, and suicidal ideation in some individuals during acute SSRI treatment. Developing a comprehensive model of how 5-HT modulates human amygdala reactivity supporting behavioral and physiological arousal will be instrumental for our understanding of basic neurobehavioral processes, their dysfunction in psychiatric illnesses, and their contribution to mechanism of treatment response.
Conflict of interest statement
In addition to the NIH grants listed above, Dr Pollock has received research support from Janssen Pharmaceuticals. He has served on the advisory board of Forest Laboratories and is a faculty member of the Lundbeck Institute. The other authors have no other disclosures or conflicts.
Figures



References
-
- Aizenstein HJ, Clark KA, Butters MA, Cochran J, Stenger VA, Meltzer CC, et al. The BOLD hemodynamic response in healthy aging. J Cogn Neurosc. 2004;16:786–793. - PubMed
-
- Blier P, de Montigny C. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology. 1999;21(2 Suppl):91S–98S. - PubMed
-
- Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007;297:1683–1696. - PubMed
-
- Brown SM, Peet E, Manuck SB, Williamson DE, Dahl RE, Ferrell RE, et al. A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol Psychiatry. 2005;10:805. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K24MH065416/MH/NIMH NIH HHS/United States
- UL1 TR000005/TR/NCATS NIH HHS/United States
- F31 MH076420/MH/NIMH NIH HHS/United States
- M01 RR000056/RR/NCRR NIH HHS/United States
- K01MH072837/MH/NIMH NIH HHS/United States
- K24 MH065416/MH/NIMH NIH HHS/United States
- K23MH064678/MH/NIMH NIH HHS/United States
- P41EB001975/EB/NIBIB NIH HHS/United States
- F31MH076420/MH/NIMH NIH HHS/United States
- K23 MH064678/MH/NIMH NIH HHS/United States
- P41 EB001975/EB/NIBIB NIH HHS/United States
- MO1RR000056/RR/NCRR NIH HHS/United States
- K01 MH072837/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources